Cellular Therapies Australia - English - Department of Health (Therapeutic Goods Administration)

cellular therapies

gilead sciences pty ltd - brexucabtagene autoleucel, quantity: 1000000 cells/kg - injection, intravenous infusion - excipient ingredients: albumin; dimethyl sulfoxide; sodium chloride - cellular therapies - tecartus is a genetically modified autologous immunocellular therapy for the treatment of patients with relapsed or refractory mantle cell lymphoma (mcl), who have received two or more lines of therapy, including a btk inhibitor, unless ineligible or intolerant to treatment with a btk inhibitor.

Cellular Therapies Australia - English - Department of Health (Therapeutic Goods Administration)

cellular therapies

gilead sciences pty ltd - axicabtagene ciloleucel, quantity: 1000000 cells/kg - injection, intravenous infusion - excipient ingredients: dimethyl sulfoxide; sodium chloride; albumin - cellular therapies - yescarta is a genetically modified autologous immunocellular therapy for the treatment of:large b-cell lymphoma - patients with relapsed or refractory large b-cell lymphoma (lbcl).yescarta is not indicated for the treatment of patients with primary central nervous system lymphoma. follicular lymphoma - patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Zetadone 10% Topical Solution Philippines - English - FDA (Food And Drug Administration)

zetadone 10% topical solution

n/a; distributor: n/a - povidone-iodine - topical solution - 10%

Zetadone 0.075 Topical Solution Philippines - English - FDA (Food And Drug Administration)

zetadone 0.075 topical solution

genace pharma distributor - povidone iodine - topical solution - 0.075

ZETAFEN PLUS TABLETAS Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

zetafen plus tabletas

unipharm international, s.a. - naproxeno sÓdico - naproxeno sÓdico....275.00 mg / acetaminofÉn....300.00 mg